Vestal Point Capital »

Achilles Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 1.5M 1.02
2024-06-30 $1.2M 1.5M 0.82

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Achilles Therapeutics

Syncona Portfolio
BML Capital Management
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Siren
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Corsair Capital Management
Baader Bank
Susquehanna International

View all funds holding Achilles Therapeutics